Sands Capital Alternatives, LLC

13D and 13G Filings

Issuer % of Class Filed
Schedule 13G · 2 securities · passive
Acumen Pharmaceuticals, Inc. 13G/A
ABOS · 00509G209
5.6% 8/13/2025
Event 6/30/2025
Klaviyo, Inc. 13G/A
KVYO · 49845K101
4.9% 5/14/2025
Event 3/31/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.